[Research progress of non-biological artificial liver support system therapy for paitents with liver failure].

Liver failure Non-biological artificial liver support system Prognosis Treatment

Journal

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
ISSN: 1007-3418
Titre abrégé: Zhonghua Gan Zang Bing Za Zhi
Pays: China
ID NLM: 9710009

Informations de publication

Date de publication:
20 Sep 2023
Historique:
medline: 1 11 2023
pubmed: 24 10 2023
entrez: 23 10 2023
Statut: ppublish

Résumé

Liver failure progresses quickly with high mortality. Non-biological artificial liver support system therapy is one of the important treatments for patients with liver failure. The basic techniques of non-biological artificial liver support system therapy include plasma exchange, plasma adsorption and continuous renal replacement therapy. In this paper, the effect and choice of these basic techniques, the treatment timing, the possible patients who may benefit, and the existing problems are summarized and discussed. We hope to provide a reference for the rational use of non-biological artificial liver support system therapy in clinical practice. 肝衰竭病情进展快,病死率高。非生物型人工肝治疗是肝衰竭的重要治疗手段之一。非生物型人工肝治疗的基本技术有血浆置换、血浆吸附和连续性肾脏替代治疗。现结合国内外有关人工肝治疗基本技术的研究进展探讨人工肝治疗肝衰竭的效果、基本技术的选择、治疗时机与可能受益的患者、存在的问题等,希望为临床合理使用人工肝治疗提供参考。.

Autres résumés

Type: Publisher (chi)
肝衰竭病情进展快,病死率高。非生物型人工肝治疗是肝衰竭的重要治疗手段之一。非生物型人工肝治疗的基本技术有血浆置换、血浆吸附和连续性肾脏替代治疗。现结合国内外有关人工肝治疗基本技术的研究进展探讨人工肝治疗肝衰竭的效果、基本技术的选择、治疗时机与可能受益的患者、存在的问题等,希望为临床合理使用人工肝治疗提供参考。.

Identifiants

pubmed: 37872099
doi: 10.3760/cma.j.cn501113-20220607-00266
doi:

Types de publication

English Abstract Journal Article

Langues

chi

Sous-ensembles de citation

IM

Pagination

1004-1008

Subventions

Organisme : National Science and Technology Major Project
ID : 2018ZX10715-003
Organisme : 1·3·5 project for Disciplines of Excellence, West China Hospital, Sichuan University
ID : ZYGD20009

Auteurs

Y J Ma (YJ)

Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu 610041, China.

L Y Du (LY)

Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu 610041, China.

L Bai (L)

Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu 610041, China.

H Tang (H)

Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu 610041, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH